MAEGHAN SMITH: Open Payments
NPI 1871256743 · KANNAPOLIS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,048 in 184 payments from 28 companies in 2025. Trend: 2023 $2,791 · 2024 $3,366 · 2025 $3,048
Food & beverage: $2,949Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $417 |
| ABBVIE INC. | 35 | $410 |
| Novo Nordisk Inc | 16 | $254 |
| Astellas Pharma US Inc | 6 | $186 |
| Bayer Healthcare Pharmaceuticals Inc. | 20 | $184 |
| PFIZER INC. | 12 | $177 |
| GlaxoSmithKline, LLC. | 10 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $155 |
| Lilly USA, LLC | 9 | $146 |
| Amgen Inc. | 9 | $138 |
Products named: AIRSUPRA, VRAYLAR, Kerendia, TRELEGY ELLIPTA, CAPLYTA, Wegovy, OTEZLA, REXULTI.
Industry payments across NC — which companies pay providers there.
